Galectin-9 in physiological and pathological conditions

被引:163
|
作者
Hirashima, M
Kashio, Y
Nishi, N
Yamauchi, A
Imaizumi, T
Kageshita, T
Saita, N
Nakamura, T
机构
[1] Kagawa Med Univ, Dept Immunol & Immunopathol, Miki, Kagawa 7610793, Japan
[2] Kagawa Med Univ, Dept Endocrinol, Miki, Kagawa 7610793, Japan
[3] Kagawa Med Univ, Dept Surg, Miki, Kagawa 7610793, Japan
[4] Hirosaki Univ, Sch Med, Inst brain Sci, Dept Vasc Biol, Hirosaki, Aomori 036, Japan
[5] Kumamoto Univ, Sch Med, Dept Dermatol, Kumamoto 860, Japan
[6] Kumamoto Univ, Sch Med, Dept Internal Med, Kumamoto 860, Japan
关键词
galectin-9 (Gal-9); eosinophil activation; cancer; apoptosis; prognosis;
D O I
10.1023/B:GLYC.0000014090.63206.2f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We first cloned galectin-9 (Gal-9)/ecalectin as a T cell-derived eosinophil chemoattractant. Gal-9 plays a role in not only accumulation but also activation of eosinophils in experimental allergic models and human allergic patients, because Gal-9 induces eosinophil chemoattraction in vitro and in vivo and activates eosinophils in many aspects. Gal-9 requires divalent galactoside-binding activity but not the linker peptide of Gal-9 to exhibit its biological functions, and an unidentified matrix metalloproteinase is involved in the release of Gal-9. Our recent studies also showed that Gal-9 has other functions, such as cell differentiation, aggregation, adhesion, and death. Now, we and other groups are on the way of investigating the regulation and function of Gal-9 in a variety of physiological and pathological conditions. In this article, we will show the possible role of Gal-9 in physiological and pathological conditions by using our recent findings.
引用
收藏
页码:593 / 600
页数:8
相关论文
共 50 条
  • [21] Galectin-9: An anticancer molecule for gallbladder carcinoma
    Tadokoro, Tomoko
    Morishita, Asahiro
    Fujihara, Shintaro
    Iwama, Hisakazu
    Niki, Toshiro
    Fujita, Koji
    Akashi, Emiko
    Mimura, Shima
    Oura, Kyoko
    Sakamoto, Teppei
    Nomura, Takako
    Tani, Joji
    Miyoshi, Hisaaki
    Yoneyama, Hirohito
    Himoto, Takashi
    Hirashima, Mitsuomi
    Masaki, Tsutomu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (03) : 1165 - 1174
  • [22] Cancer Therapy Due to Apoptosis: Galectin-9
    Fujita, Koji
    Iwama, Hisakazu
    Oura, Kyoko
    Tadokoro, Tomoko
    Samukawa, Eri
    Sakamoto, Teppei
    Nomura, Takako
    Tani, Joji
    Yoneyama, Hirohito
    Morishita, Asahiro
    Himoto, Takashi
    Hirashima, Mitsuomi
    Masaki, Tsutomu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (01):
  • [23] Therapeutic potential of Galectin-9 in human disease
    Wiersma, Valerie R.
    de Bruyn, Marco
    Helfrich, Wijnand
    Bremer, Edwin
    MEDICINAL RESEARCH REVIEWS, 2013, 33 : E102 - E126
  • [24] Galectin-9 is a Novel Modulator of Epithelial Restitution
    Robinson, Brian Scott
    Saeedi, Bejan
    Naudin, Crystal
    Arthur, Connie
    Darby, Trevor
    Jones, Rheinallt
    Stowell, Sean
    Neish, Andrew
    FASEB JOURNAL, 2018, 32 (01):
  • [25] The Significance of Galectin-1 and Galectin-9 Expression in Endometrial Carcinoma
    Sun, Xiao-fei
    Dai, Shu-yan
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2020, 85 (01) : 34 - 40
  • [26] Galectin-9 in autoimmune hepatitis Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis
    Matsuoka, Naoki
    Kozuru, Hideko
    Koga, Tomohiro
    Abiru, Seigo
    Yamasaki, Kazumi
    Komori, Atsumasa
    Fujita, Yuya
    Tenmoku, Junpei
    Asano, Tomoyuki
    Sato, Shuzo
    Suzuki, Eiji
    Furuya, Makiko
    Kobayashi, Hiroko
    Watanabe, Hiroshi
    Naganuma, Atsushi
    Yoshizawa, Kaname
    Shimada, Masaaki
    Ario, Keisuke
    Yamashita, Haruhiro
    Kohno, Hiroshi
    Kaneyoshi, Toshihiko
    Nakamura, Minoru
    Furukawa, Hiroshi
    Takahashi, Atsushi
    Kawakami, Atsushi
    Ohira, Hiromasa
    Yatsuhashi, Hiroshi
    Migita, Kiyoshi
    MEDICINE, 2019, 98 (35) : e16924
  • [27] Different angioregulatory activity of monovalent galectin-9 isoforms
    Aanhane, Ed
    Schulkens, Iris A.
    Heusschen, Roy
    Castricum, Kitty
    Leffler, Hakon
    Griffioen, Arjan W.
    Thijssen, Victor L.
    ANGIOGENESIS, 2018, 21 (03) : 545 - 555
  • [28] Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
    Kong, Fei
    Jin, Meishan
    Cao, Donghui
    Jia, Zhifang
    Liu, Yawen
    Jiang, Jing
    PEERJ, 2020, 8
  • [29] Galectin-9 Changes Its Function to Maintain Homeostasis
    Hirashima, Mitsuomi
    Niki, Toshiro
    Masaki, Tsutomu
    TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 2018, 30 (172) : SJ55 - SJ64
  • [30] Induction of galectin-9 production by viral infection in the lung
    Katoh, Shigeki
    Ikeda, Masaki
    Shimizu, Hiroki
    Fukushima, Kiyoyasu
    Oka, Mikio
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46